A short induction regimen of interferon-α is not effective for treatment of relapse in chronic hepatitis C: a randomized trial-Reference-Cited by-同舟云学术

A short induction regimen of interferon-α is not effective for treatment of relapse in chronic hepatitis C: a randomized trial

Published:1999-09 Issue:5 Volume:6 Page:381-386
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:

Author:

Poynard T.,Daurat V.,Chevret S.,Moussalli J.,Degos F.,Bailly F.,Borotto E.,Buffet C.,Bartolomei-Portal I.,Richardet J. P.,Riachi G.,Calmus Y.,Bréchot C.,Vidaud M.,Olivi M.,Bedossa P.,Riffaud P. Chaumet,Chastang C.

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2893.1999.00170.x/fullpdf

Reference17 articles.

1. Epidemiology of hepatitis C.;Alter;Hepatology,1997

2. Hepatitis C: global prevalence.;World Health Organization;Wkly Epidemiol Rev,1997

3. Long-term mortality after transfusion-associated non-A non-B hepatitis.;Seeff;N Engl J Med,1992

4. Clinical outcomes after transfusion-associated hepatitis C.;Tong;N Engl J Med,1995

5. Mortality from liver cancer and liver disease in haemophilic men and boys given blood products contaminated with hepatitis C.;Darby;Lancet,1997

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C;Cochrane Database of Systematic Reviews;2013-01-31

2. Daily induction combination treatment with alpha 2b interferon and ribavirin or standard combination treatment in naive chronic hepatitis C patients. A multicentre randomized controlled trial *;Journal of Viral Hepatitis;2003-11

3. Retreatment with interferon and ribavirin vs interferon alone according to viraemia in interferon responder-relapser hepatitis C patients: a prospective multicentre randomized controlled study;Journal of Viral Hepatitis;2003-05

4. Reinforced interferon alpha-2b and ribavirin is more effective than standard combination therapy in the retreatment of chronic hepatitis C previously nonresponsive to interferon: a randomized trial;Journal of Viral Hepatitis;2003-05

5. Chronic hepatitis C patients with a post-treatment virological relapse re-treated with an induction dose of 18 MU interferon-alpha in combination with ribavirin and amantadine: a two-arm randomized pilot study;Journal of Viral Hepatitis;2003-05